Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi

Investigative Radiology

Volumn 37, Issue 11, 2002, Pages 587-593

  Schumann, Patricia A ^a   Christiansen, Jonathan P ^a   Quigley, Rachel M ^a   McCreery, Thomas P ^a   Sweitzer, Robert H ^a   Unger, Evan C ^a   Lindner, Jonathan R ^a   Matsunaga, Terry O ^a  

^a ImaRx Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR; FLUOROCARBON; LIGAND; LIPID;

ANIMAL CELL; ANIMAL MODEL; ARTERIOLE; ARTICLE; BINDING AFFINITY; BLOOD CLOTTING; CELL CULTURE; CREMASTER MUSCLE; IMAGE ENHANCEMENT; IMAGING; IMMOBILIZED CELL; IN VITRO STUDY; MALE; MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBUS; ULTRASOUND; VENULE;

EID: 0036830189     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200211000-00001     Document Type: Article

References (29)

1. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol 1968;3:356-366.
2. Feinstein SB, Ten-Cate FJ, Zwehl W, et al. Two-dimensional contrast echocardiography 1. In vitro development and quantitative analysis of echo contrast agents. J Am Coll Cardio 1984;3:14-29.
3. Unger EC, Lund P, et al. Aerosomes as blood pool and cardiovascular contrast agents for US: In vivo studies [abstract]. Radiology 1991; 181:225.
4. Singhal S, Moser CC, et al. Surfactant-stabilized microbubbles as ultrasound contrast agents: Stability study of Span 60 and Tween 80 mixtures using a Langmuir trough. Langmuir 1993;9:2426-2429.
5. Narayan P, Wheatley, MA. Preparation and characterization of hollow microcapsules for use as ultrasound contrast agents. Polym Eng Sci 1999;30:2242-2255.
6. Schlief R. Galactose-based echo-enhancing agents. In: Goldberg, BB, ed. Ultrasound Contrast Agents. 1st Ed. London: Martin Dunitz; 1997:75-82.
7. Unger E, Fritz TA, et al. Therapeutic Drug Delivery Systems 1996; US Patent No. 5,580,575.
8. Schneider M, Arditi M, Barrau MB, et al. BR1: A new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol 1995;30:451-457.
9. Unger EC, Lund PJ, Shen DK, et al. Nitrogen-filled liposomes as a vascular US contrast agent: Preliminary evaluation. Radiology 1992;185:453-456.
10. Forsberg F, Wu Y, Merton DA, et al, Parenchymal enhancement and tumor visualization using a new sonographic contrast agent. J Ultrasound Med 1995;14:949-957.
11. Christy DH, Wallace KD, et al. Quantitative intravascular ultrasound: Demonstration using a novel site targeted acoustic contrast agent. Proc IEEE Ultrason Symp 1995;95CH35844:1125-1128.
12. Lanza GM, Wallace KD, Scott MJ, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996;94:3334-3340.
13. Lanza GM, Wallace KD, et al. Development of a novel site-targeted ultrasonic contrast agent. In: Nanda, N, Schlief, R, Goldberg, BB, eds. Ultrasound Contrast Agents. Netherlands: Kluwer Academic Publishers, 1997;6545-6667.
14. Wu Y, Unger EC, McCreery T, et al. Binding and lysing of blood clots using MRX-408. Invest Radiol 1998;33:880-885.
15. Unger E, Metzger P, Krupinski E, et al. The use of a thrombus-specific ultrasound contrast agent to detect thrombus in arteriovenous fistulae. Invest Radiol 2000;35:86-89.
16. Vannan M, McCreery T, Li P, et al. Ultrasound mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. J Am Soc Echocardiogr 2002; 15:224-226.
17. Hawiger J. Platelets in Thrombosis and Rethrombosis. In: Haber E, ed. Scientific Am: Molecular Cardiovascular Medicine. New York, NY: Scientific Am; 1995:157-176.
18. Tachibana K, Tachibana S. Albumin Microbubble Echo-Contrast, Material as an Enhancer for Ultrasound Accelerated Thrombolysis Am Heart. J 1995;92:1148-1150.
19. Schumann PA, Quigley R, et al. Design, Synthesis, and Calorimetric Studies of Novel Bioconjugates for Liposomal Drug Delivery 2002; in preparation.
20. Tangelder GJ, Slaaf DW, Arts T, et al. Wall shear rate in arterioles in vivo: Least estimates from platelet velocity profiles. Am J Physiol 1988;254:H1059-H1064.
21. Reneman RS, Woldhuis B, et al. Concentration and Velocity Profiles of blood cells in the microcirculation. In: Hwang, NHC, Tritto, VT, Yen, MRT, eds. Advances in Cardiovascular Engineering. New York, NY: Plenum: 1995:25-40.
22. Lindner JR, Coggins MP, Kaul S, et al. Microbubble persistence in the microcirculation during ischemia-reperfusion and inflammation: Integrin- and complement-mediated adherence to activated leukocytes, Circulation 2000;101:668-675.
23. Oude Egebrink M, Tangelder GJ, et al. Fluid Dynamics and the thromboembolic reaction in mesenteric arterioles venules. Am J Physiol 1991:29:H1826-H1833.
24. Lindner JR, Song J, Christiansen J, et al. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 2001;104:2107-2112.
25. Lindner JR, Song J, Xu F, et al. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 2000;102:2745-2750.
26. Takeuchi M, Ogunyankin K, Pandian NG, et al. Enhanced visualization of intravascular and left atrial appendage thrombus with the use of a thrombus-targeting ultrasonographic contrast agent (MRX-408A1): In vivo experimental echocardiographic studies. J Am Soc Echocardiogr 1999;12:1015-1021.
27. Omran H, Jung W, Rabahieth R, et al. Imaging of thrombi and assessment of left atrial appendage function: A prospective study comparing transthoracic and transoesophageal echocardiography. Heart 1999;81:192-198.
28. Kannel WB, Abbott RD, et al. Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982;306:1018-1022.
29. Luo H, Birnbaum Y, et al. Enhancement of thrombolysis in vivo without skin and soft tissue damage by transcutaneous ultrasound. Thromb Res 1998;89:171-177.